Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. (Q33404027)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. |
scientific article |
Statements
1 reference
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. (English)
1 reference
Patrick Y Wen
1 reference
Eudocia Q Lee
1 reference
Timothy F Cloughesy
1 reference
Jan Drappatz
1 reference
Susan M Chang
1 reference
John Kuhn
1 reference
Frank Lieberman
1 reference
Michael D Prados
1 reference
Lauren Abrey
1 reference
Kenneth Aldape
1 reference
Kathleen R Lamborn
1 reference
H Ian Robins
1 reference
W K Alfred Yung
1 reference
Victor A Levin
1 reference
Janet E Dancey
1 reference
John J Wright
1 reference
Mark R Gilbert
1 reference
24 October 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference